Erez Aminov Sells 55,410 Shares of MIRA Pharmaceuticals, Inc. Stock

MIRA Stock   1.15  0.10  8.00%   
About 66% of MIRA Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading MIRA Pharmaceuticals, Common stock suggests that many investors are alarmed at this time. The current market sentiment, together with MIRA Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use MIRA Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
  
MIRA Pharmaceuticals, Inc. CEO Erez Aminov sold 55,410 shares of MIRA Pharmaceuticals stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of 1.39, for a total value of 77,019.90. Following the sale, the chief executive officer now owns 1,105,790 shares of the companys

Read at thelincolnianonline.com
news
  

MIRA Pharmaceuticals, Fundamental Analysis

We analyze MIRA Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MIRA Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MIRA Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

MIRA Pharmaceuticals, is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

MIRA Pharmaceuticals, Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MIRA Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of MIRA Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals, by comparing valuation metrics with similar companies.

Complementary Tools for MIRA Stock analysis

When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments